MARKET

CELG

Celgene
CELG
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
19.84
4.606
6.37
77,001,936,000.00
About CELG
Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.
More

CELG News

More
The No. 1 Pharma Stock Just Crushed Earnings Views — Is BMY Stock A Buy?
Pharmaceutical company Bristol Myers advanced in 2019 despite shareholder opposition to its Celgene buyout. Now that Bristol has officially acquired Celgene, is it time to buy BMY stock?
Investor's Business Daily · 05/20 13:00
Legend Biotech Seeks U.S. Capital For Pipeline Advance
Seeking Alpha - Article · 05/19 20:38
ADC Therapeutics Cuts Price In 2nd IPO Attempt
Seeking Alpha - Article · 05/11 16:29
Is The No. 1 Pharmaceutical Stock A Buy As It Approaches A Breakout?
Investor's Business Daily · 04/22 12:00
The No. 1 Pharma Company Nabbed A Key Approval — But Is It A Buy?
Investor's Business Daily · 04/16 13:00
FDA's OKs new use of Acceleron and Bristol-Myers Squibb's luspatercept
Seeking Alpha - Article · 04/03 21:26
These 3 Biotech Stocks Are Outperforming Their Peers Here's Why
Investor's Business Daily · 04/02 15:00
IPO Update: Keros Therapeutics Proposes IPO Terms
Seeking Alpha - Article · 04/02 14:55

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Celgene stock information, including NASDAQ:CELG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELG stock news, and many more online research tools to help you make informed decisions.